Abstract:The action of protein kinases and protein phosphatases is essential for multiple physiological responses. Each protein kinase displays its own unique substrate specificity and a regulatory mechanism that may be modulated by association with other proteins. Protein kinases are classified as dual-specificity kinases and dual-specificity phosphatases. Dual-specificity phosphatases are important signal transduction enzymes that regulate various cellular processes in coordination with protein kinases and play an important role in obesity. Impairment of insulin signaling in obesity is largely mediated by the activation of the inhibitor of kappa B-kinase beta and the c-Jun N-terminal kinase (JNK). Oxidative stress and endoplasmic reticulum (ER) stress activate the JNK pathway which suppresses insulin biosynthesis. Adenosine monophosphate (AMP)-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) are important for proper regulation of glucose metabolism in mammals at both the hormonal and cellular levels. Additionally, obesity-activated calcium/calmodulin dependent-protein kinase II/p38 suppresses insulin-induced protein kinase B phosphorylation by activating the ER stress effector, activating transcription factor-4. To alleviate lipotoxicity and insulin resistance, promising targets are pharmacologically inhibited. Nifedipine, calcium channel blocker, stimulates lipogenesis and adipogenesis by downregulating AMPK and upregulating mTOR, which thereby enhances lipid storage. Contrary to the nifedipine, metformin activates AMPK, increases fatty acid oxidation, suppresses fatty acid synthesis and deposition, and thus alleviates lipotoxicity. Obese adults with vascular endothelial dysfunction have greater endothelial cells activation of unfolded protein response stress sensors, RNA-dependent protein kinase-like ER eukaryotic initiation factor-2 alpha kinase (PERK), and activating transcription factor-6. The transcriptional regulation of adipogenesis in obesity is influenced by AGC (protein kinase A (PKA), PKG, PKC) family signaling kinases. Obesity may induce systemic oxidative stress and increase reactive oxygen species in adipocytes. An increase in intracellular oxidative stress can promote PKC-β activation. Activated PKC-β induces growth factor adapter Shc phosphorylation. Shc-generated peroxides reduce mitochondrial oxygen consumption and enhance triglyceride accumulation and lipotoxicity. Liraglutide attenuates mitochondrial dysfunction and reactive oxygen species generation. Co-treatment of antiobesity and antidiabetic herbal compound, berberine with antipsychotic drug olanzapine decreases the accumulation of triglyceride. While low-dose rapamycin, metformin, amlexanox, thiazolidinediones, and saroglitazar protect against insulin resistance, glucagon-like peptide-1 analog liraglutide inhibits palmitate-induced inflammation by suppressing mTOR complex 1 (mTORC1) activity and protects against lipotoxicity.

Regulation of Energy Metabolism by Receptor Tyrosine Kinase Ligands

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

Novel advances in understanding fatty acid-binding G protein-coupled receptors and their roles in controlling energy balance

The Role of BDNF and TrkB in the Central Control of Energy and Glucose Balance: An Update

G protein-coupled receptors as regulators of energy homeostasis.

G Protein-Coupled Receptors in Energy Homeostasis

Cell signaling by receptor tyrosine kinases

Mechanistic Target of Rapamycin Complex 1: From a Nutrient Sensor to a Key Regulator of Metabolism and Health

Cross-talk between AMPK and mTOR in regulating energy balance.

Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer

Metabolic Regulation of Cell Fate and Function.

Leptin signaling and leptin resistance.

Role of Mitogen-Activated Protein (MAP) Kinase Pathways in Metabolic Diseases

Protein Kinases in Obesity, and the Kinase-Targeted Therapy

The Regulatory Role of Key Metabolites in the Control of Cell Signaling

Cannabinoid Receptors in Metabolic Regulation and Diabetes

Transcriptional Regulation of Pyruvate Dehydrogenase Kinase

Mechanisms of receptor tyrosine kinase activation in cancer

Insulin signalling and the regulation of glucose and lipid metabolism

The Function of Xenobiotic Receptors in Metabolic Diseases.

AMPK signalling in health and disease